Viral hepatitis in patients on hemodialysis.
Anna WinstonAlysse G WurcelCraig GordonNitender GoyalPublished in: Seminars in dialysis (2020)
Hepatitis B and hepatitis C (HCV) prevalence are higher in people on hemodialysis (HD) than the general population. Through implementation of prevention interventions including vaccines, serologic screening, and post-exposure management, transmissions linked to HD have decreased dramatically. In this manuscript, we review epidemiology of viral hepatitis, summarize current screening and vaccine recommendations, and appraise the available data about efforts to decrease incidence within HD facilities, including isolation of people with viral hepatitis within HD units. Also included is a discussion of the highly effective all-oral HCV treatment options and treatment for HCV in people awaiting kidney transplant.
Keyphrases
- end stage renal disease
- hepatitis c virus
- chronic kidney disease
- peritoneal dialysis
- sars cov
- risk factors
- newly diagnosed
- human immunodeficiency virus
- ejection fraction
- primary care
- healthcare
- quality improvement
- prognostic factors
- physical activity
- electronic health record
- big data
- clinical practice
- machine learning
- combination therapy
- coronavirus disease
- deep learning
- hiv infected